Stemiotics, Inc.

stemiotics, inc. offers state-of-the-art cellular reprogramming services at breakthrough pricing of $1000 per line. we generate ipscs from human fibroblasts using messenger rna transfection, the fastest and most efficient method yet devised for inducing pluripotency in these cells. the mrna system is inherently footprint-free and avoids the inconveniences and residual risks associated with alternative non-integrating reprogramming strategies. to maximize the clinical relevance of our ipscs, we have developed a derivation pipeline which eliminates the use of animal products, feeder cells, conditioned media or small-molecule pathway inhibitors. see our website or contact us for more details.